Treatment of chronic or relapsing COVID-19 in immunodeficiency

Brown, L-AK, Moran, E, Goodman, A et al. (19 more authors) (2021) Treatment of chronic or relapsing COVID-19 in immunodeficiency. Journal of Allergy and Clinical Immunology, 149 (2). pp. 557-561. ISSN 0091-6749

Abstract

Metadata

Authors/Creators:
  • Brown, L-AK
  • Moran, E
  • Goodman, A
  • Baxendale, H
  • Bermingham, W
  • Buckland, M
  • AbdulKhaliq, I
  • Jarvis, H
  • Hunter, M
  • Karanam, S
  • Patel, A
  • Jenkins, M
  • Robbins, A
  • Khan, S
  • Simpson, T
  • Jolles, S
  • Underwood, J
  • Savic, S ORCID logo https://orcid.org/0000-0001-7910-0554
  • Richter, A
  • Shields, A
  • Brown, M
  • Lowe, DM
Copyright, Publisher and Additional Information: © 2021 American Academy of Allergy, Asthma & Immunology. This is an author produced version of a journal article published in Journal of Allergy and Clinical Immunology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: COVID-19; immunodeficiency; remdesivir; SARS-CoV-2; therapeutic monoclonal
Dates:
  • Accepted: 22 October 2021
  • Published (online): 12 November 2021
  • Published: November 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Nov 2021 16:46
Last Modified: 12 Nov 2022 01:13
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.jaci.2021.10.031
Related URLs:

Export

Statistics